Click For Photo: https://techcrunch.com/wp-content/uploads/2019/01/Headshot-Christina-Dog.jpg?w=600
One in every three dogs gets cancer, according to the National Canine Cancer Foundation. OneHealth, a startup that just raised a $5 million seed round led by Andreessen Horowitz’s Bio fund with participation from Lerer Hippeau and Y Combinator, aims to make it easier for humans to treat canine cancer, which is the number one disease killer of pups.
“Prevalence and incidence for cancer is much higher with dogs,” OneHealth founder and CEO Christina Lopes told TechCrunch over the phone.
OneHealth - Fidocure - Product - Dog - Cancer
OneHealth’s Fidocure product is designed to make treating your dog’s cancer more accessible and affordable. It specifically utilizes next-generation gene sequencing to better understand the genetic mutation that is causing an individual dog’s cancer. From there, Fidocare offers recommendations and an action plan to the human, outlining the best therapeutic implications and targeted treatment.
“The purpose of the company is actionability,” Lopes said. “The test is the first step. From there, if there’s a certain mutation present, we’ll say what the FDA-approve drugs with data in dogs available are. We’ve been able to then work with pharmaceutical partners and other compounding pharmacies.”
Dog - Cancer - OneHealth - Product
If your dog gets diagnosed with cancer, your veterinarian may recommend OneHealth’s product. Still, you’ll continue to...
Wake Up To Breaking News!
A pox on both their houses!